← All trials
NCT01819272
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2013
- Primary completion
- Sep 1, 2013
- Completion date
- Sep 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 6 / —
- Source
- AACT · pre-existing
Sponsors
- Elcelyx Therapeutics, Inc.Lead sponsor
- L-Marc Research CenterOverall official - principal investigator
- University of Texas, San AntonioOverall official - principal investigator
- BiofortisOverall official - principal investigator
- National Research Institute - WilshireOverall official - principal investigator
- Alliance Against Diabetes / AAD Clinical ResearchOverall official - principal investigator
- Encompass Clinical ResearchOverall official - principal investigator
- Medical Research South, LLCOverall official - principal investigator
- Protenium Clinical Research, LLCOverall official - principal investigator
- Castlerock Clinical Research Consultants, LLCOverall official - principal investigator
- Achieve Clinical Research, LLCOverall official - principal investigator
- Big Sky Clinical ResearchOverall official - principal investigator
- Sterling Research Group, LtdOverall official - principal investigator
- Charlotte Clinical ResearchOverall official - principal investigator
- Creekside Endocrine AssociatesOverall official - principal investigator
- Dallas Diabetes and Endocrine CenterOverall official - principal investigator
- Searcy Medical CenterOverall official - principal investigator
- New Orleans Center for Clinical ResearchOverall official - principal investigator
- Pinnacle Research GroupOverall official - principal investigator
- Rainier Clinical Research CenterOverall official - principal investigator
- Spartanburg Medical ResearchOverall official - principal investigator
- Craig S Thompson MD LLCOverall official - principal investigator
- RAS Health LtdOverall official - principal investigator
- John Muir Physician Network Clinical Research CenterOverall official - principal investigator
- National Clinical Research - Richmond, Inc.Overall official - principal investigator
- Kentucky Diabetes Endocrinology CenterOverall official - principal investigator
- Meridien ResearchOverall official - principal investigator
- Jacksonville Center for Clinical ResearchOverall official - principal investigator
- AXIS Clinicals LimitedOverall official - principal investigator
- Texas Diabetes & Endocrinology, P.A.Overall official - principal investigator
- Diablo Clinical ResearchOverall official - principal investigator
- Compass ResearchOverall official - principal investigator
- Juno ResearchOverall official - principal investigator
- Pioneer Clinical Research LLCOverall official - principal investigator
- PMG ResearchOverall official - principal investigator
- Willamette Valley Cancer InstituteOverall official - principal investigator
- Progressive Clinical ResearchOverall official - principal investigator
- Apex BioscienceOverall official - principal investigator
- Coastal Carolina ResearchOverall official - principal investigator
- Partners in HealthOverall official - principal investigator
- Rochester Clinical ResearchOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.